Company Filing History:
Years Active: 2021
Title: Innovations in Radiotherapy: The Contributions of Samuel Debruin
Introduction
Samuel Debruin is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of radiotherapy through his innovative work on silicon photomultiplier array-based multispectral optical probes. His research focuses on enhancing the quality assurance of radiotherapy and improving tumor tracking during treatment.
Latest Patents
Samuel Debruin holds a patent for his invention titled "Silicon photomultiplier array-based multispectral optical probes for image-guided radiotherapy." This patent addresses the challenges associated with Cerenkov Emission (CE) during external beam radiation therapy (EBRT) from a linear accelerator (Linac). The invention aims to provide a useful tool for radiotherapy quality assurance and offers potential applications for online tracking of tumors during treatment.
Career Highlights
Debruin's work emphasizes the importance of molecular probing of cancer status during treatment delivery. He identifies the limitations of CE detection sensitivity and the need for flexible tools in complex treatment environments. His research explores the feasibility of using silicon photomultipliers (SiPMs) for low light detection, which can significantly enhance the sensitivity of tumor status interrogation during EBRT. This innovative approach contrasts the performance of SiPMs with commercially available silicon photodiodes (PDs).
Collaborations
Samuel Debruin collaborates with esteemed colleagues, including Issam I El Naqa and Ibrahim Oraiqat. Their combined expertise contributes to the advancement of radiotherapy technologies and the development of innovative solutions for cancer treatment.
Conclusion
Samuel Debruin's contributions to the field of radiotherapy through his innovative patent demonstrate the potential for improved cancer treatment methodologies. His work not only enhances the quality assurance of radiotherapy but also paves the way for more effective tumor tracking during treatment.